Search research articles
Contact Us
Filters
Showing results (251-260 of 441) with videos related to
Page
of 45
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2003
Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer
Francisco J Esteva, Aysegul A Sahin, George Z Rassidakis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2005
The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer
Thomas A Buchholz, Amit K Garg, Nitin Chakravarti, et al.
The Oncologist
|
May 26, 2021
Prognostic Factors for Overall Survival in Patients with Hormone Receptor-Positive Advanced Breast Cancer: Analyses From PALOMA-3
Hope S Rugo, Massimo Cristofanilli, Sybille Loibl, et al.
Oncotarget
|
September 1, 2018
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications
Angela Toss, Federico Piacentini, Laura Cortesi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 22, 2011
Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotype
James M Reuben, Bang-Ning Lee, Hui Gao, et al.
Nature Communications
|
March 3, 2018
Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer
Ben O'Leary, Sarah Hrebien, James P Morden, et al.
Critical Reviews in Oncology/Hematology
|
December 30, 2019
Performance of a novel Next Generation Sequencing circulating tumor DNA (ctDNA) platform for the evaluation of samples from patients with metastatic breast cancer (MBC)
Lorenzo Gerratana, Qiang Zhang, Ami Naimish Shah, et al.
The Oncologist
|
February 9, 2017
A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone
Jianqing Lin, Sheel A Patel, Ashwin R Sama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
A Phase I study of docetaxel plus cyclophosphamide in solid tumors followed by a Phase II study as first-line therapy in metastatic breast cancer
Jonathan C Trent, Vicente Valero, Daniel J Booser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2004
Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes
Massimo Cristofanilli, Ana Gonzalez-Angulo, Nour Sneige, et al.
Page
of 45
Search research articles
Search
Showing results (251-260 of 441) with videos related to
Sort By:
Page
of 45
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2003
Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer
Francisco J Esteva, Aysegul A Sahin, George Z Rassidakis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2005
The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer
Thomas A Buchholz, Amit K Garg, Nitin Chakravarti, et al.
The Oncologist
|
May 26, 2021
Prognostic Factors for Overall Survival in Patients with Hormone Receptor-Positive Advanced Breast Cancer: Analyses From PALOMA-3
Hope S Rugo, Massimo Cristofanilli, Sybille Loibl, et al.
Oncotarget
|
September 1, 2018
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications
Angela Toss, Federico Piacentini, Laura Cortesi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 22, 2011
Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotype
James M Reuben, Bang-Ning Lee, Hui Gao, et al.
Nature Communications
|
March 3, 2018
Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer
Ben O'Leary, Sarah Hrebien, James P Morden, et al.
Critical Reviews in Oncology/Hematology
|
December 30, 2019
Performance of a novel Next Generation Sequencing circulating tumor DNA (ctDNA) platform for the evaluation of samples from patients with metastatic breast cancer (MBC)
Lorenzo Gerratana, Qiang Zhang, Ami Naimish Shah, et al.
The Oncologist
|
February 9, 2017
A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone
Jianqing Lin, Sheel A Patel, Ashwin R Sama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
A Phase I study of docetaxel plus cyclophosphamide in solid tumors followed by a Phase II study as first-line therapy in metastatic breast cancer
Jonathan C Trent, Vicente Valero, Daniel J Booser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2004
Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes
Massimo Cristofanilli, Ana Gonzalez-Angulo, Nour Sneige, et al.
Page
of 45